Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease [Phase 3]

View source ↗

Summary

Phase 3 study to evaluate the efficacy and safety of Bemdaneprocel in adults with Parkinson's disease; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Bemdaneprocel (Bemdaneprocel)

Snippet

Sponsor: BlueRock Therapeutics | Conditions: Parkinsons Disease (PD) | Phase 3 | Status: RECRUITING